在患有严重2型喘的患者中,杜皮卢马布的心声图效应
Corrado Pelaia1, Giuseppe Armentaro1, Chiara Lupia2
1Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro - Catanzaro, Italy.
Pulmonary pharmacology & therapeutics
|January 21, 2026
概括
杜皮卢马布在12个月内显著改善了严重喘患者的心脏和肺功能. 基线左心室全球纵向菌株 (LV-GLS) 预测了临床缓解,突出了其在喘管理中的作用.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 严重的喘与肺功能不良和心血管风险增加有关.
- 由IL-4和IL-13驱动的2型炎症导致呼吸道和心脏重塑.
- 杜皮卢马布是一种IL-4Rα抗剂,改善了呼吸系统的结果,但其对心脏的影响需要更多的研究.
研究的目的:
- 评估dupilumab对严重2型喘心声测量的12个月影响.
- 评估dupilumab治疗与临床缓解之间的关联.
- 为了确定治疗反应的潜在心脏预测因素.
主要方法:
- 一个单一中心的观察性研究包括24名重症2型喘患者接受dupilumab治疗.
- 心声和肺功能测试在基线和12个月后进行.
- 临床缓解被定义为零恶化,不使用口服皮质类固醇,喘控制测试 (ACT) 得分≥20和预测的1秒前支气管扩展剂强迫呼吸量 (FEV1) ≥80%.
主要成果:
- 杜皮卢马布治疗显著改善左心室全球纵向应变 (LV-GLS) 和右心室全球纵向应变 (RV-GLS),以及TAPSE和TAPSE/S-PAP比率.
- 观察到FEV1和FEF25-75的显著增长,剩余体积和呼吸道阻力减少.
- 45.83%的患者实现了临床缓解. 基线LV-GLS是缓解的强有力的预测指标 (AUC = 0.832).
结论:
- 杜皮卢马布在严重喘中显示出心脏和肺功能显著改善.
- 药物可能有助于实现临床缓解.
- 基线LV-GLS是缓解的潜在预测标志物,支持喘护理中的心血管评估.
相关概念视频
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
01:22Diabetes Mellitus: Type 2 and Gestational
4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
192
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
192
01:26Asthma-II: Pathophysiology and Classification
4.2K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.2K
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
01:24Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K